- Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. The Lancet Global health. 2018.
- Chhatwal J, Chen Q, Bethea ED, Ladd MA, Mueller PP, Hutin Y, et al. Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs. The lancet Gastroenterology & hepatology. 2018;3(12):819.
- Degeling K, Franken MD, May AM, van Oijen MGH, Koopman M, Punt CJA, et al. Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients. Cancer epidemiology. 2018;57:60-7.
- Ionescu AM, Mpobela Agnarson A, Kambili C, Metz L, Kfoury J, Wang S, et al. Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis. Expert review of pharmacoeconomics & outcomes research. 2018;18(6):677-89.
HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Tuesday 15 January 2019
December’s CEAs.....
We’ve completed our quick search for CEA’s published last month. In the right-hand column of this blog is a CEA Archive of all records. Below are those in our areas of interest.